Medipost Co Ltd

078160

Company Profile

  • Business description

    Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

  • Contact

    21, Daewangpangyo-ro 644
    Bundang-gu
    Gyeonggi-do
    Seongnam
    KOR

    T: +82 234656650

    http://www.medi-post.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    324

Stocks News & Analysis

stocks

Qantas earnings: Jetstar capitalising on weaker domestic competition

Qantas’ budget brand performing well, with segment earnings up 55%.
stocks

Nvidia Earnings: No signs of a slowdown in demand for AI chips

A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
stocks

ASX results reaction: WiseTech, Woolies, Sigma and more

A round up of notable stories and reactions as ASX reporting season rolls on.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,168.007.10-0.08%
CAC 407,654.2553.65-0.70%
DAX 4023,487.33550.00-2.29%
Dow JONES (US)45,295.81249.07-0.55%
FTSE 1009,116.6979.65-0.87%
HKSE25,496.55120.87-0.47%
NASDAQ21,279.63175.92-0.82%
Nikkei 22542,310.49121.700.29%
NZX 50 Index13,149.2216.060.12%
S&P 5006,415.5444.72-0.69%
S&P/ASX 2008,900.601.50-0.02%
SSE Composite Index3,858.1317.40-0.45%

Market Movers